NCS Multistage Holdings (NASDAQ: NCSM) reported robust financial results for the fourth quarter of 2024, highlighting strategic international market expansion and improved financial performance. The company's total revenues reached $45.0 million, representing a 28% year-over-year increase driven primarily by strong international market performance.
International revenues were particularly impressive, surging 279.8% to $4.4 million. This growth was predominantly attributed to successful projects in the Middle East tracer diagnostics and North Sea frac systems. The company's strategic focus on high-margin international markets has positioned it for continued growth, with particular potential in accommodative jurisdictions like Argentina.
Geographically, the company experienced mixed results. While the U.S. market saw product sales increase by 29.1%, service revenues declined by 9.5%. Canada demonstrated strong performance with a 19.5% year-over-year growth. Consolidated gross margins expanded from 36.6% in the fourth quarter of 2023 to 43.1% in the same period of 2024.
The company's financial health remains strong, with a net working capital of $56.4 million and a total liquidity position of $46.0 million. Free cash flow for the year-to-date period reached $9.5 million, approximately 14% of the current market capitalization.
Looking forward, NCS Multistage Holdings anticipates flat revenue performance in the first quarter of 2025 across U.S., Canadian, and international markets. The company has guided full-year revenue expectations between $165.0 million and $175.0 million, with adjusted EBITDA projected between $20.0 million and $23.0 million.
Valuation analyses using discounted cash flow and enterprise value-to-EBITDA methods suggest a potential share price range between $31.76 and $39.15, with midpoint valuations of $34.36 and $36.86 respectively.
